electroCore (ECOR) Gross Profit Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | 53.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.29% |
| Dec 31, 2025 | 62.05% |
| Sep 30, 2025 | 63.22% |
| Jun 30, 2025 | 52.99% |
| Mar 31, 2025 | 54.77% |
| Dec 31, 2024 | 71.54% |
| Sep 30, 2024 | 69.26% |
| Jun 30, 2024 | 80.93% |
| Mar 31, 2024 | 75.69% |
| Dec 31, 2023 | 234.47% |
| Sep 30, 2023 | 73.76% |
| Jun 30, 2023 | 83.51% |
| Mar 31, 2023 | 74.68% |
| Dec 31, 2022 | 89.05% |
| Sep 30, 2022 | 73.48% |
| Jun 30, 2022 | 69.67% |
| Mar 31, 2022 | 82.83% |
| Dec 31, 2021 | 89.81% |
| Sep 30, 2021 | 175.89% |
| Jun 30, 2021 | 80.28% |
| Mar 31, 2021 | 196.46% |
| Dec 31, 2020 | 64.92% |
| Sep 30, 2020 | 67.91% |
| Jun 30, 2020 | 51.58% |